Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Income from Continuing Operations (2019 - 2026)

Biodesix filings provide 8 years of Income from Continuing Operations readings, the most recent being 8178000.0 for Q1 2026.

  • On a quarterly basis, Income from Continuing Operations rose 24.42% to 8178000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 32946000.0, a 17.69% increase, with the full-year FY2025 number at 35589000.0, up 16.76% from a year prior.
  • Income from Continuing Operations hit 8178000.0 in Q1 2026 for Biodesix, down from 4026000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 4026000.0 in Q4 2025 to a low of 18764000.0 in Q1 2023.
  • Median Income from Continuing Operations over the past 5 years was 10821000.0 (2025), compared with a mean of 11532882.35.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 150.21% in 2022 and later skyrocketed 52.08% in 2025.
  • Biodesix's Income from Continuing Operations stood at 16440000.0 in 2022, then surged by 44.05% to 9199000.0 in 2023, then grew by 8.67% to 8401000.0 in 2024, then skyrocketed by 52.08% to 4026000.0 in 2025, then tumbled by 103.13% to 8178000.0 in 2026.
  • The last three reported values for Income from Continuing Operations were 8178000.0 (Q1 2026), 4026000.0 (Q4 2025), and 9125000.0 (Q3 2025) per Business Quant data.